Aqua-Med Consulting S.R.L.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Systemic sclerosis (scleroderma)2 trials
• Ankylosing spondylitis1 trial
• Sjögren's disease1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Completed3 trials
• Not yet recruiting1 trial

Lead sponsor

• Boehringer Ingelheim2 trials
• Alfasigma S.p.A.1 trial
• Argenx1 trial

Running trials

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Boehringer Ingelheim· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Systemic sclerosis (scleroderma)1 recruiting

Closed trials

• Completed

  A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY)

  NCT06684847· Phase 3· Argenx· Source

• Active, not recruiting

  A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis

  NCT05785611· Phase 3· Alfasigma S.p.A.· Source

• Completed

  A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

  NCT05559580· Phase 2· Boehringer Ingelheim· Source